“METHOD DEVELOPMENT AND VALIDATION OF DAPAGLIFLOZIN BY RP-HPLC”, Journal of Pharmaceutical Negative Results, pp. 4316–4335, Dec. 2022, doi: 10.47750/pnr.2022.13.S06.571.